SRS Capital Advisors Inc. Boosts Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

SRS Capital Advisors Inc. boosted its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 15.6% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 3,208 shares of the medical equipment provider’s stock after purchasing an additional 432 shares during the period. SRS Capital Advisors Inc.’s holdings in Intuitive Surgical were worth $1,674,000 as of its most recent SEC filing.

A number of other large investors have also made changes to their positions in the company. Bennett Selby Investments LP boosted its holdings in shares of Intuitive Surgical by 3.9% in the fourth quarter. Bennett Selby Investments LP now owns 449 shares of the medical equipment provider’s stock worth $234,000 after buying an additional 17 shares during the last quarter. Onefund LLC boosted its stake in shares of Intuitive Surgical by 1.9% during the 4th quarter. Onefund LLC now owns 947 shares of the medical equipment provider’s stock worth $494,000 after acquiring an additional 18 shares during the last quarter. LVW Advisors LLC grew its position in shares of Intuitive Surgical by 1.3% during the 4th quarter. LVW Advisors LLC now owns 1,448 shares of the medical equipment provider’s stock valued at $756,000 after acquiring an additional 19 shares during the period. Wesbanco Bank Inc. grew its position in shares of Intuitive Surgical by 1.6% during the 4th quarter. Wesbanco Bank Inc. now owns 1,216 shares of the medical equipment provider’s stock valued at $635,000 after acquiring an additional 19 shares during the period. Finally, FSM Wealth Advisors LLC increased its stake in shares of Intuitive Surgical by 3.7% in the 4th quarter. FSM Wealth Advisors LLC now owns 526 shares of the medical equipment provider’s stock worth $275,000 after purchasing an additional 19 shares in the last quarter. 83.64% of the stock is currently owned by institutional investors.

Insider Transactions at Intuitive Surgical

In other Intuitive Surgical news, CFO Jamie Samath sold 270 shares of Intuitive Surgical stock in a transaction on Tuesday, December 10th. The shares were sold at an average price of $540.15, for a total transaction of $145,840.50. Following the completion of the transaction, the chief financial officer now directly owns 8,757 shares of the company’s stock, valued at $4,730,093.55. The trade was a 2.99 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, EVP Myriam Curet sold 2,401 shares of the business’s stock in a transaction on Thursday, February 27th. The shares were sold at an average price of $581.00, for a total transaction of $1,394,981.00. Following the transaction, the executive vice president now owns 353 shares in the company, valued at $205,093. This trade represents a 87.18 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders sold 8,077 shares of company stock worth $4,620,025. 0.90% of the stock is currently owned by company insiders.

Intuitive Surgical Trading Up 1.7 %

ISRG opened at $573.15 on Friday. The stock has a 50-day moving average of $569.87 and a 200 day moving average of $529.06. Intuitive Surgical, Inc. has a 12 month low of $364.17 and a 12 month high of $616.00. The firm has a market cap of $204.14 billion, a P/E ratio of 89.42, a P/E/G ratio of 5.85 and a beta of 1.39.

Wall Street Analyst Weigh In

Several equities analysts recently weighed in on the company. Leerink Partners lifted their target price on Intuitive Surgical from $490.00 to $548.00 in a research report on Monday, January 27th. CICC Research assumed coverage on Intuitive Surgical in a research report on Monday, January 27th. They set a “neutral” rating and a $550.00 price objective on the stock. JPMorgan Chase & Co. increased their target price on shares of Intuitive Surgical from $575.00 to $675.00 and gave the stock an “overweight” rating in a report on Friday, January 24th. Evercore ISI lifted their price target on shares of Intuitive Surgical from $490.00 to $530.00 in a report on Monday, January 27th. Finally, Jefferies Financial Group increased their price objective on shares of Intuitive Surgical from $475.00 to $575.00 in a research note on Monday, January 27th. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating and sixteen have assigned a buy rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $613.10.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.